Atlas Trials

Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

Clinical trial NCT04011618 · UNKNOWN

Trial details

NCT number
NCT04011618
Sponsor
University of Guadalajara
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2019-09-17
Primary completion
2021-12-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.